Method
Level · gp.fundamentals.debt_to_revenue
Raw value 131.70% · OPTIONAL
· Pharmaceutical Preparations
RESEARCH SNAPSHOTABEONA THERAPEUTICS INC.'s latest supported as-filed period reports revenue of $11.4M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 131.70% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 4.21% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -153.74% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 2745.00% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 52.03% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 63.30% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue changed across a low base; Operating margin moved 557803 bp higher; Operating income increased 40.1%.
3 evidence-backed componentsOperating income changed +40.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Each point keeps the date investors could first observe it and its accession.
ABEO · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-041068SEC ↗10-QAug 13, 2026Period Jun 30, 20260001493152-26-037576SEC ↗8-KAug 13, 2026Period Aug 13, 20260001493152-26-037575SEC ↗4Jul 22, 2026Period Jul 21, 20260001493152-26-034246SEC ↗4Jul 9, 2026Period Jul 9, 20260001493152-26-032746SEC ↗4Jul 9, 2026Period Jul 9, 20260001493152-26-032744SEC ↗4Jul 9, 2026Period Jul 9, 20260001493152-26-032742SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Level · gp.fundamentals.operating_margin
Raw value -119.97% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 44.12% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 29.60% · OPTIONAL
Cash & equivalents changed -65.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +17.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating margin changed +557803 basis points from the comparable as-filed period.
Working capital changed -29.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current assets changed -29.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current liabilities changed -28.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001493152-26-032740